Device type · MXK
Device, Analysis, Anterior Segment
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MXK
Ophthalmic
Device class
Class II
FDA decisions since 2015
11
510(k), De Novo and PMA
Adverse event reports
1
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Device, Analysis, Anterior Segment
- Product code
- MXK
- Device class
- Class II
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.1850
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for MXK
Latest FDA decisions
The 8 newest of 11 since 2015.
- Pentacam® Cornea OCT510(k)
K251848 · Decided Mar 13, 2026 · 270 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
K252348 · Decided Dec 18, 2025 · 142 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
- BOSS510(k)
K223700 · Decided Aug 16, 2024 · 613 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
- MYAH510(k)
K222933 · Decided Jun 29, 2023 · 276 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
- MYAH510(k)
K211868 · Decided Mar 1, 2022 · 258 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
- Myopia Master510(k)
K202989 · Decided Jul 14, 2021 · 287 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
- Pentacam AXL Wave510(k)
K201724 · Decided Oct 21, 2020 · 120 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
Sis Ag, Surgical Instrument Systems
K182659 · Decided Jul 25, 2019 · 303 days after receipt
Device type: Device, Analysis, Anterior Segment (MXK) · Ophthalmology
Reports received
1
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Manufacturing, Packaging or Shipping Problem1
- Nonstandard Device1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Oculus Pentacam AXL Wave, Ref 70020, CE 0123Open, Classified
Z-2482-2023 · Started Aug 8, 2023 · Posted by FDA Aug 30, 2023
Reason given: Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.
Cause as FDA categorized it: Process control
- Oculus Pentacam AXL , Ref 70100, CE 0123Open, Classified
Z-2483-2023 · Started Aug 8, 2023 · Posted by FDA Aug 30, 2023
Reason given: Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.
Cause as FDA categorized it: Process control
- Oculus Myopia Master , Ref 68100, CE 0123Open, Classified
Z-2484-2023 · Started Aug 8, 2023 · Posted by FDA Aug 30, 2023
Reason given: Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.
Cause as FDA categorized it: Process control
Z-1672-2022 · Started Jul 8, 2022
Reason given: Due to a software issue, IOL calculator printout often does not accurately reflect the alignment axis and incision position when planning toric IOLs
Cause as FDA categorized it: Software design
- Pentacam AXL REF 70100, Pentacam HR REF 70900. Used to image the anterior segment of the eye.Open, Classified
Z-1673-2022 · Started Jul 8, 2022
Reason given: Due to a software issue, IOL calculator printout often does not accurately reflect the alignment axis and incision position when planning toric IOLs
Cause as FDA categorized it: Software design
Z-1674-2022 · Started Jul 8, 2022
Reason given: Due to a software issue, IOL calculator printout often does not accurately reflect the alignment axis and incision position when planning toric IOLs
Cause as FDA categorized it: Software design
Z-0635-2018 · Started Nov 21, 2017
Reason given: The device software versions have an anomaly which may produce an erroneous marking for the quality specification value
Cause as FDA categorized it: Software design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.